These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1941379)

  • 1. Thyroid function after treatment of brain tumors in children.
    Ogilvy-Stuart AL; Shalet SM; Gattamaneni HR
    J Pediatr; 1991 Nov; 119(5):733-7. PubMed ID: 1941379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.
    Livesey EA; Brook CG
    Arch Dis Child; 1989 Apr; 64(4):593-5. PubMed ID: 2751333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
    Constine LS; Rubin P; Woolf PD; Doane K; Lush CM
    J Clin Oncol; 1987 Nov; 5(11):1841-51. PubMed ID: 3681371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):136-40. PubMed ID: 12519842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy.
    Ricardi U; Corrias A; Einaudi S; Genitori L; Sandri A; di Montezemolo LC; Besenzon L; Madon E; Urgesi A
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1287-94. PubMed ID: 11483340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
    Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
    N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
    Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
    J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine disorders following treatment of childhood brain tumours.
    Livesey EA; Hindmarsh PC; Brook CG; Whitton AC; Bloom HJ; Tobias JS; Godlee JN; Britton J
    Br J Cancer; 1990 Apr; 61(4):622-5. PubMed ID: 2109998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).
    Bölling T; Geisenheiser A; Pape H; Martini C; Rübe C; Timmermann B; Fischedick K; Kortmann RD; Gerss J; Koch R; Willich N
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e787-91. PubMed ID: 21167655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
    de Wit MC; de Bruin HG; Eijkenboom W; Sillevis Smitt PA; van den Bent MJ
    Neurology; 2004 Aug; 63(3):535-7. PubMed ID: 15304589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors.
    Goldwein JW; Radcliffe J; Packer RJ; Sutton LN; Lange B; Rorke LB; D'Angio GJ
    Cancer; 1993 Apr; 71(8):2647-52. PubMed ID: 8384073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation.
    Lando A; Holm K; Nysom K; Rasmussen AK ; Feldt-Rasmussen U; Petersen JH; Müller J
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):21-5. PubMed ID: 11453948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary dysfunction after radiation for brain tumors.
    Constine LS; Woolf PD; Cann D; Mick G; McCormick K; Raubertas RF; Rubin P
    N Engl J Med; 1993 Jan; 328(2):87-94. PubMed ID: 8416438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.